Page 10 - Hellen Kim News Today

Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results - read this article along with other careers information, tips and advice on BioSpace

Soligenix: Phase III Trial Success Offers New Hope to Those Living with Rare Disease

Shining a Light on a New Hope for a Rare Form of Non-Hodgkins Lymphoma: Conversation with Dr. Ellen Kim on HyBryte™ from Soligenix July 06, 2021 15:39 ET | Source: PCG Digital PCG Digital New York, NY, July 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- PCG Digital -- A rare form of non-Hodgkin’s lymphoma, cutaneous T-cell lymphoma (CTCL) has no current FDA-approved first-line therapies. There are roughly 3,000 new CTCL cases in the United States each year, wi...

Soligenix Announces Recent Accomplishments And First Quarter 2021 Financial Results News provided by Share this article Share this article PRINCETON, N.J., May 17, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the quarter ended March 31, 2021. ...

Broad Efficacy and Improved Safety Profile of HyBryte™ Presented at Society for Investigative Dermatology Virtual Meeting News provided by Share this article Share this article PRINCETON, N.J., May 4, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Ellen Kim, MD, Medical Director, Dermatolog...

HyBryte™ Expanded Efficacy and Safety Data Presented at the American Academy of Dermatology Meeting News provided by Share this article Share this article PRINCETON, N.J., April 26, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Ellen Kim, MD, Medical Director, Dermatology Clinic, Perelman C...

Johns Hopkins welcomes first members of Class of 2025 The group of 520 talented high schoolers who applied for early decision admission to the university include inventors, policy advocates, community organizers, and engineers By Hub staff report / Published Dec 11, 2020 A group of 520 talented high school students from across the globe who applied for early admission to Johns Hopkins University were offered admission today, making them the first member...